biotechnology

See the following -

A DIY Pharmaceutical Revolution Is Coming—If It Doesn’t Kill Us First

Kristen V. Brown | Gizmodo | August 2, 2017

As Mixael Laufer tells it, the vision came to him in El Salvador. Laufer was visiting Central America as a human rights envoy, touring a tiny, rural mountain town with the Marin County Peace and Justice Coalition. When he arrived at the town’s medical clinic, it had just run out of birth control. “I thought to myself, ‘This is a country where there are there are methamphetamine and ecstasy labs everywhere. Birth control isn’t that much more complicated,’” Laufer told Gizmodo. “‘Why aren’t these people just making their own birth control?’”...

Read More »

A Way For Biopharma To Disclose More Trial Data

Ken Getz | Medical Marketing & Media | December 26, 2012

[...] At a time when some regulatory bodies and biopharma companies are increasing their transparency initiatives involving access to clinical-trial data, disclosing trial results to volunteers could also go a long way toward strengthening public confidence. Read More »

ABLE, DUKE And OSHL Conduct Workshop On Meeting The Challenges Of Developing New Anticancer Therapies

Press Release | Association of Biotechnology Led Enterprises (ABLE), Duke University , Open Source Health Laboratories (OSHL) | September 17, 2012

Strategic planning, clinical trial initiatives, translational research, and regulatory elements of the drug development process were discussed

Read More »

Agricultural Biotechnology 'Should Be Open Source'

T. V. Padma | SciDev.Net | September 13, 2012

Open source biotechnology, through which biotechnology inventions are made freely available for others to use and improve upon, could help developing countries overcome hurdles created by stringent intellectual property rights (IPRs), a study says. Read More »

BIOFAB - an Open Source Language for Programming Cells

Daniela Hernandez | WIRED | April 19, 2013

Drew Endy is the co-director of the International Open Facility Advancing Biotechnology — BIOFAB, for short — where he’s part of a team that’s developing a language that will use genetic data to actually program biological cells. Read More »

Biohacking Healthcare - Part 2

Eric Valor | Forbes | September 18, 2012

One of the most valuable research tools is a model of the type of problem you are trying to solve. This allows for study of the problem mechanism and allows attempts at solving various parts of the problem without disrupting an actual patient or when such is unavailable... Read More »

Clinovo Ranked #9 Among 494 Biotech By Business Intelligence Company SIGNL

Press Release | Clinovo | November 21, 2013

SIGNL, a service that tracks the fastest-growing companies worldwide, ranked Clinovo at 9th position among 494 companies in the pharmaceutical, medical device and biotechnology industry. From startups to big businesses, SIGNL measures the success of a company’s engine by aggregating and quantifying evidence of a business growth. Read More »

Developer Of Sensitive Devices To Detect Diseases, Proteins Gets In-Q-Tel Funding

Dawn Lim | Nextgov | November 15, 2012

Biotech firm Quanterix raised $18.5 million in a funding round joined by CIA venture capital wing In-Q-Tel, the company announced. Read More »

Dr Kogelnik Wins Award For Business Model With Open Medicine Institute!

Staff Writer | Phoenix Rising | November 21, 2012

As part of Global Entrepreneurship Week, Santa Clara County StartUp Cup held their event finals. From a pool of more than 50 applicants, three were recognized for their businesses models. The first place winner was Open Medicine Institute. Read More »

Embracing Open-Source Biotech: DNA Freeware May Out-Innovate Patented Genes

Carole Jacques | Lux Research | August 28, 2013

...biotechnology companies need to incorporate open-source into their innovation plans in order to succeed in the emerging landscape, according to Lux Research. Read More »

Established Journals To Publish Under Open Access Model

Press Release | John Wiley & Sons, Inc. | February 19, 2013

John Wiley & Sons, Inc., announced today that Journal of Cellular and Molecular Medicine and Microbial Biotechnology have joined the Wiley Open Access publishing program. All articles in these two journals are now open access and free to view, download and share. Read More »

Harvard Law Conference Surveys Troubles With Health Care

Andy Oram | EMR & EHR | March 30, 2016

It is salubrious to stretch oneself and regularly attend a conference in a related field. At the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, one can bask in the wisdom of experts who are truly interdisciplinary (as opposed to people like me, who is simply undisciplined). Their Tenth Anniversary Conference drew about 120 participants. The many topics–which included effects of the Supreme Court rulings on the Affordable Care Act and other cases, reasons that accountable care and other efforts haven’t lowered costs, stresses on the pharmaceutical industry, and directions in FDA regulation–contained several insights for health IT professionals...

Read More »

Health Care M&A Spending Grows In Q2 2013, Compared With Q1 2013, According To Irving Levin Associates, Inc.

Staff Writer | Irving Levin Associates. Inc. | July 29, 2013

Health care merger and acquisition activity strengthened in the second quarter of 2013. Deal volume was up 10% versus the previous quarter, with 223 deals announced. However, the quarter underperformed (-15%) in comparison with the same quarter a year ago, according to The Health Care M&A Report. [...] Read More »

How Does The Gates Foundation Spend Its Money To Feed The World?

Staff Writer | Grain | November 4, 2014

At some point in June this year, the total amount given as grants to food and agriculture projects by the Bill and Melinda Gates Foundation surpassed the US$3 billion mark. It marked quite a milestone. From nowhere on the agricultural scene less than a decade ago, the Gates Foundation has emerged as one of the world's major donors to agricultural research and development...

Read More »

Killing Gene Patents Could Revitalize Biotech

Daniela Hernandez | Wired | June 14, 2013

The U.S. Supreme Court’s unanimous ruling that naturally occurring genes can’t be patented looks, on the surface, like terrible news for biotech companies. Read More »